2022
DOI: 10.1007/s00330-021-08533-1
|View full text |Cite
|
Sign up to set email alerts
|

Dynamic 3D radiomics analysis using artificial intelligence to assess the stage of COVID-19 on CT images

Abstract: Objective To develop a dynamic 3D radiomics analysis method using artificial intelligence technique for automatically assessing four disease stages (i.e., early, progressive, peak, and absorption stages) of COVID-19 patients on CT images. Methods The dynamic 3D radiomics analysis method was composed of three AI algorithms (the lung segmentation, lesion segmentation, and stage-assessing AI algorithms) that were trained and tested on 313,767 CT images from 520 COVID-19 pa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 24 publications
(21 reference statements)
0
1
0
Order By: Relevance
“…In addition, several studies were conducted at the intersection era of COVID-19 to develop CT-based radiomic signatures for diagnostic and predictive purposes with the aim to improve clinical decision-making. 17,[23][24][25][26][27][28][29][30][31][32] Most aforementioned studies utilized datasets consisting of the dichotomy of COVID-19 pneumonia versus other non-COVID-19 pneumonia or COVID-19 vs. normal patients. However, some CXR or CT studies included other lung diseases as well.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, several studies were conducted at the intersection era of COVID-19 to develop CT-based radiomic signatures for diagnostic and predictive purposes with the aim to improve clinical decision-making. 17,[23][24][25][26][27][28][29][30][31][32] Most aforementioned studies utilized datasets consisting of the dichotomy of COVID-19 pneumonia versus other non-COVID-19 pneumonia or COVID-19 vs. normal patients. However, some CXR or CT studies included other lung diseases as well.…”
Section: Introductionmentioning
confidence: 99%